United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market (2025-2031) | Size & Revenue, Growth, Companies, Outlook, Share, Forecast, Trends, Value, Segmentation, Competitive Landscape, Industry, Analysis

Market Forecast By Nature of Tests (ABO, Antibody Screening/Indirect Antiglobulin, Antibody Panels, Antigen Typing, Antiglobulin, Rh, Crossmatching), By Applicaions (Hospitals, Diagnostic Las, Research Labs, Blood Banks) And Competitive Landscape
Product Code: ETC9970763 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Outlook
  • Market Size of United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market, 2024
  • Forecast of United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market, 2031
  • Historical Data and Forecast of United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Revenues & Volume for the Period 2021- 2031
  • United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Trend Evolution
  • United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Drivers and Challenges
  • United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Price Trends
  • United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Porter's Five Forces
  • United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Industry Life Cycle
  • Historical Data and Forecast of United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume By Nature of Tests for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume By ABO for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume By Antibody Screening/Indirect Antiglobulin for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume By Antibody Panels for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume By Antigen Typing for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume By Antiglobulin for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume By Rh for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume By Crossmatching for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume By Applicaions for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume By Diagnostic Las for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume By Research Labs for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume By Blood Banks for the Period 2021- 2031
  • United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Import Export Trade Statistics
  • Market Opportunity Assessment By Nature of Tests
  • Market Opportunity Assessment By Applicaions
  • United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Top Companies Market Share
  • United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Company Profiles
  • United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market - Industry Life Cycle

3.4 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market - Porter's Five Forces

3.5 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume Share, By Nature of Tests, 2021 & 2031F

3.6 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume Share, By Applicaions, 2021 & 2031F

4 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for personalized medicine and targeted therapies

4.2.2 Growing prevalence of infectious diseases in the United States

4.2.3 Advancements in molecular testing technologies

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval of molecular blood typing and infectious disease diagnostic tests

4.3.2 Limited awareness and adoption of molecular testing techniques among healthcare providers

5 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Trends

6 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market, By Types

6.1 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market, By Nature of Tests

6.1.1 Overview and Analysis

6.1.2 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Nature of Tests, 2021- 2031F

6.1.3 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By ABO, 2021- 2031F

6.1.4 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Antibody Screening/Indirect Antiglobulin, 2021- 2031F

6.1.5 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Antibody Panels, 2021- 2031F

6.1.6 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Antigen Typing, 2021- 2031F

6.1.7 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Antiglobulin, 2021- 2031F

6.1.8 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Rh, 2021- 2031F

6.2 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market, By Applicaions

6.2.1 Overview and Analysis

6.2.2 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Hospitals, 2021- 2031F

6.2.3 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Diagnostic Las, 2021- 2031F

6.2.4 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Research Labs, 2021- 2031F

6.2.5 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Blood Banks, 2021- 2031F

7 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Import-Export Trade Statistics

7.1 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Export to Major Countries

7.2 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Imports from Major Countries

8 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Key Performance Indicators

8.1 Percentage increase in the number of molecular blood typing and infectious disease tests conducted annually

8.2 Adoption rate of molecular testing technologies by healthcare facilities

8.3 Number of research and development initiatives focused on improving molecular testing accuracy and efficiency

9 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market - Opportunity Assessment

9.1 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Opportunity Assessment, By Nature of Tests, 2021 & 2031F

9.2 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Opportunity Assessment, By Applicaions, 2021 & 2031F

10 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market - Competitive Landscape

10.1 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenue Share, By Companies, 2024

10.2 United States (US) Molecular Blood Typing, Grouping and Infectious Disease NAT Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All